首页> 美国卫生研究院文献>Oncology Letters >Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cells
【2h】

Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cells

机译:pEGFP-N1-hPer2重组质粒的构建及其在骨肉瘤细胞中的表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to construct the eukaryotic expression vector pEGFP-N1-hPer2 and assess its expression in the human osteosarcoma cell line MG63. Total mRNA was extracted from human osteosarcoma MG63 cells, the human period 2 (hPer2) gene was obtained by reverse transcription-polymerase chain reaction (RT-PCR) and cloned into the pEGFP-N1 vector, then the recombinant pEGFP-N1-hPer2 plasmid was constructed and transfected into MG63 cells using Lipofectamine 2000. The expression of hPer2 in MG63 cells was measured by quantitative RT-PCR and western blot analysis. The accurate construction of pEGFP-N1-hPer2 was verified by double enzyme digestion and DNA sequencing. hPer2 gene expression in the transfected cells was assessed by RT-qPCR and western blot analysis. In conclusion, the recombinant pEGFP-N1-hPer2 plasmid was constructed successfully, and expressed effectively in MG63 cells.
机译:这项研究的目的是构建真核表达载体pEGFP-N1-hPer2,并评估其在人骨肉瘤细胞MG63中的表达。从人骨肉瘤MG63细胞中提取总mRNA,通过逆转录-聚合酶链反应(RT-PCR)获得人2期(hPer2)基因,并将其克隆到pEGFP-N1载体中,然后重组pEGFP-N1-hPer2质粒用Lipofectamine 2000将其构建并转染到MG63细胞中。通过定量RT-PCR和蛋白质印迹分析来测量hPer2在MG63细胞中的表达。通过双重酶消化和DNA测序证实了pEGFP-N1-hPer2的准确构建。通过RT-qPCR和蛋白质印迹分析评估转染细胞中hPer2基因的表达。结论成功构建了重组pEGFP-N1-hPer2质粒,并在MG63细胞中有效表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号